DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Ragni MV.
New and emerging agents for the treatment of hemophilia: focus on extended half-life recombinant clotting proteins.
Drugs 2015;
75 (14) 1587-1600
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.